Inovio Pharmaceuticals (INO) Thoughts After INO-4800 Update, Oppenheimer Reiterates Outperform
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh reiterated an Outperform rating on Inovio Pharmaceuticals (NASDAQ: INO) after the company provided an update of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE